CARDIOVASCULAR DISEASE, SIGNALING, GENE/CELL THERAPY AND ADVANCED NANOBIOMATERIALS
Küçük Resim Yok
Tarih
2024
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Jomard Publishing
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Cardiovascular biomaterials (also known as CB) are the most common type of biomaterials, both in terms of investments and demand. This review article compiles information on the CB and categorizes it into three primary categories: metals, polymers, and biological materials. Blood compatibility is one of the primary parameters that restricts the use of biomaterials for cardiovascular applications. Within the scope of this study, a number of significant figures concerning blood compatibility are investigated. There were a variety of surface modification techniques that were being utilized at the moment in order to enhance the compatibility of the CB. For the purpose of gaining a deeper comprehension, a number of contemporary applications of surface modification techniques on materials for cardiovascular devices were also discussed. Last but not least, the utilization of induced human pluripotent stem cells, the endothelization of cardiac implants, and the current trend of CB. As a result of the rapid expansion of the field of CB, a significant number of new researchers and academics are developing an interest in it. This overview will serve as a one-stop shop for quickly gaining an understanding of the fundamental studies that have been conducted in the field of CB. © 2024, Jomard Publishing. All rights reserved.
Açıklama
Anahtar Kelimeler
cancer, cancer metabolism, cell signaling, drug delivery, drug development, Nanomedicine
Kaynak
Advances in Biology and Earth Sciences
WoS Q Değeri
Scopus Q Değeri
Q1
Cilt
9
Sayı
Special Issue
